Focus on Therapeutic Options for Surgically Resectable Pancreatic Adenocarcinoma Based on Novel Biomarkers

Pancreatic ductal adenocarcinoma remains associated with a poor prognosis, even when diagnosed at an early stage. Consequently, it is imperative to carefully consider the available therapeutic options and tailor them based on clinically relevant biomarkers. In our comprehensive review, we specifical...

Descripción completa

Detalles Bibliográficos
Autores principales: Olivari, Alessandro, Agnetti, Virginia, Garajová, Ingrid
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Commentary
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10378659/
https://www.ncbi.nlm.nih.gov/pubmed/37504335
http://dx.doi.org/10.3390/curroncol30070475

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10378659/
https://www.ncbi.nlm.nih.gov/pubmed/37504335
http://dx.doi.org/10.3390/curroncol30070475

Ejemplares similares